These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2944481)

  • 1. Concentration of ciprofloxacin in human prostatic tissue after oral administration.
    Dan M; Golomb J; Gorea A; Braf Z; Berger SA
    Antimicrob Agents Chemother; 1986 Jul; 30(1):88-9. PubMed ID: 2944481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ciprofloxacin distribution in prostatic tissue and fluid following oral administration.
    Boerema JB; Dalhoff A; Debruyne FM
    Chemotherapy; 1985; 31(1):13-8. PubMed ID: 3156024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion of ciprofloxacin into prostatic fluid.
    Dalhoff A; Weidner W
    Eur J Clin Microbiol; 1984 Aug; 3(4):360-2. PubMed ID: 6489327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of ciprofloxacin after intravenous and increasing oral doses.
    Bergan T; Thorsteinsson SB; Kolstad IM; Johnsen S
    Eur J Clin Microbiol; 1986 Apr; 5(2):187-92. PubMed ID: 2941278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacology of orally administered ciprofloxacin.
    Brittain DC; Scully BE; McElrath MJ; Steinman R; Labthavikul P; Neu HC
    Drugs Exp Clin Res; 1985; 11(5):339-41. PubMed ID: 2941262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Penetration of ciprofloxacin into gynecological tissues following oral and intravenous administration.
    Goormans E; Dalhoff A; Kazzaz B; Branolte J
    Chemotherapy; 1986; 32(1):7-17. PubMed ID: 2936582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple-dose pharmacokinetics and safety of ciprofloxacin in normal volunteers.
    Gonzalez MA; Uribe F; Moisen SD; Fuster AP; Selen A; Welling PG; Painter B
    Antimicrob Agents Chemother; 1984 Nov; 26(5):741-4. PubMed ID: 6517556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-dose pharmacokinetics of oral ciprofloxacin in patients with cystic fibrosis.
    Goldfarb J; Wormser GP; Inchiosa MA; Guideri G; Diaz M; Gandhi R; Goltzman C; Mascia AV
    J Clin Pharmacol; 1986 Mar; 26(3):222-6. PubMed ID: 2937812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of ciprofloxacin in healthy volunteers after oral and intravenous administration.
    Borner K; Höffken G; Lode H; Koeppe P; Prinzing C; Glatzel P; Wiley R; Olschewski P; Sievers B; Reinitz D
    Eur J Clin Microbiol; 1986 Apr; 5(2):179-86. PubMed ID: 2941277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of single-dose oral ciprofloxacin in patients undergoing chronic ambulatory peritoneal dialysis.
    Shalit I; Greenwood RB; Marks MI; Pederson JA; Frederick DL
    Antimicrob Agents Chemother; 1986 Jul; 30(1):152-6. PubMed ID: 2944477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraprostatic concentration of ciprofloxacin and its activity against urinary pathogens.
    Hoogkamp-Korstanje JA; van Oort HJ; Schipper JJ; van der Wal T
    J Antimicrob Chemother; 1984 Dec; 14(6):641-5. PubMed ID: 6440885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of ciprofloxacin after oral and parenteral administration.
    Höffken G; Lode H; Prinzing C; Borner K; Koeppe P
    Antimicrob Agents Chemother; 1985 Mar; 27(3):375-9. PubMed ID: 3158275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of ciprofloxacin in the dog prostate and various tissues.
    Frimodt-Møller PC; Dørflinger T; Madsen PO
    Urol Res; 1984; 12(6):283-6. PubMed ID: 6240821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and tolerance of ciprofloxacin after sequential increasing oral doses.
    Tartaglione TA; Raffalovich AC; Poynor WJ; Espinel-Ingroff A; Kerkering TM
    Antimicrob Agents Chemother; 1986 Jan; 29(1):62-6. PubMed ID: 2942101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single and multiple dose pharmacokinetics of ciprofloxacin.
    Ullmann U; Giebel W; Dalhoff A; Koeppe P
    Eur J Clin Microbiol; 1986 Apr; 5(2):193-6. PubMed ID: 2941279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concentrations of ciprofloxacin in serum and prostatic tissue in patients undergoing transurethral resection.
    Grabe M; Forsgren A; Björk T
    Eur J Clin Microbiol; 1986 Apr; 5(2):211-2. PubMed ID: 2424755
    [No Abstract]   [Full Text] [Related]  

  • 17. Ciprofloxacin concentrations in bone and muscle after oral dosing.
    Fong IW; Ledbetter WH; Vandenbroucke AC; Simbul M; Rahm V
    Antimicrob Agents Chemother; 1986 Mar; 29(3):405-8. PubMed ID: 2940971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of three oral formulations of ciprofloxacin.
    Davis RL; Koup JR; Williams-Warren J; Weber A; Smith AL
    Antimicrob Agents Chemother; 1985 Jul; 28(1):74-7. PubMed ID: 2931047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of high-pressure liquid chromatography and microbiological assay for the determination of biliary elimination of ciprofloxacin in humans.
    Brogard JM; Jehl F; Monteil H; Adloff M; Blickle JF; Levy P
    Antimicrob Agents Chemother; 1985 Aug; 28(2):311-4. PubMed ID: 2939796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ciprofloxacin pharmacokinetics in patients with cystic fibrosis.
    Bender SW; Dalhoff A; Shah PM; Strehl R; Posselt HG
    Infection; 1986; 14(1):17-21. PubMed ID: 2937737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.